Progress in the study of the correlation between sepsis and intestinal microecology

被引:2
作者
Tao, Yan-Lin [1 ]
Wang, Jing-Ran [2 ]
Liu, Miao [3 ]
Liu, Ya-Nan [1 ]
Zhang, Jin-Qiu [4 ]
Zhou, Yi-Jing [4 ]
Li, Shao-wei [4 ]
Zhu, Shu-Fen [5 ]
机构
[1] Inner Mongolia Med Univ, Affiliated Hosp, Dept Crit Care Med, Hohhot, Inner Mongolia, Peoples R China
[2] Inner Mongolia Med Univ, Affiliated Hosp, Dept Surg ICU, Hohhot, Inner Mongolia, Peoples R China
[3] Dingzhou Peoples Hosp, Dept Resp Med, Hebei, Peoples R China
[4] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Gastroenterol, Linhai, Zhejiang, Peoples R China
[5] Inner Mongolia Med Univ, Affiliated Hosp, Phys Examinat Ctr, Hohhot, Inner Mongolia, Peoples R China
基金
中国国家自然科学基金;
关键词
sepsis; gut microbiota; high-throughput sequencing; inflammatory response; immune suppression; FECAL MICROBIOTA TRANSPLANTATION; GUT MICROBIOTA; MECHANISMS; CELLS;
D O I
10.3389/fcimb.2024.1357178
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis, a disease with high incidence, mortality, and treatment costs, has a complex interaction with the gut microbiota. With advances in high-throughput sequencing technology, the relationship between sepsis and intestinal dysbiosis has become a new research focus. However, owing to the intricate interplay between critical illness and clinical interventions, it is challenging to establish a causal relationship between sepsis and intestinal microbiota imbalance. In this review, the correlation between intestinal microecology and sepsis was summarized, and new therapies for sepsis intervention based on microecological target therapy were proposed, and the shortcomings of bacterial selection and application timing in clinical practice were addressed. In conclusion, current studies on metabolomics, genomics and other aspects aimed at continuously discovering potential probiotics are all providing theoretical basis for restoring intestinal flora homeostasis for subsequent treatment of sepsis.
引用
收藏
页数:15
相关论文
共 93 条
[1]   The gut microbiome's role in the development, maintenance, and outcomes of sepsis [J].
Adelman, Max W. ;
Woodworth, Michael H. ;
Langelier, Charles ;
Busch, Lindsay M. ;
Kempker, Jordan ;
Kraft, Colleen ;
Martin, Greg S. .
CRITICAL CARE, 2020, 24 (01)
[2]   Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis [J].
Agudelo-Ochoa, Gloria M. ;
Valdes-Duque, Beatriz E. ;
Giraldo-Giraldo, Nubia A. ;
Jaillier-Ramirez, Ana M. ;
Giraldo-Villa, Adriana ;
Acevedo-Castano, Irene ;
Yepes-Molina, Monica A. ;
Barbosa-Barbosa, Janeth ;
Benitez-Paez, Alfonso .
GUT MICROBES, 2020, 12 (01)
[3]   The Intestinal Epithelium: Central Coordinator of Mucosal Immunity [J].
Allaire, Joannie M. ;
Crowley, Shauna M. ;
Law, Hong T. ;
Chang, Sun-Young ;
Ko, Hyun-Jeong ;
Vallance, Bruce A. .
TRENDS IN IMMUNOLOGY, 2018, 39 (09) :677-696
[4]   Cinnamaldehyde protects against rat intestinal ischemia/reperfusion injuries by synergistic inhibition of NF-κB and p53 [J].
Almoiliqy, Marwan ;
Wen, Jin ;
Xu, Bin ;
Sun, Yu-chao ;
Lian, Meng-qiao ;
Li, Yan-li ;
Qaed, Eskandar ;
Al-Azab, Mahmoud ;
Chen, Da-peng ;
Shopit, Abdullah ;
Wang, Li ;
Sun, Peng-yuan ;
Lin, Yuan .
ACTA PHARMACOLOGICA SINICA, 2020, 41 (09) :1208-1222
[5]   Scaffold hopping of agomelatine leads to enhanced antidepressant effects by modulation of gut microbiota and host immune responses [J].
An, Qi ;
Li, Chungen ;
Chen, Yaxing ;
Yang, Yang ;
Song, Rao ;
Zhou, LiangXue ;
Li, Jiong ;
Tong, Aiping ;
Luo, Youfu .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2020, 192
[6]   Fecal microbiota transplantation in disease therapy [J].
Antushevich, Hanna .
CLINICA CHIMICA ACTA, 2020, 503 :90-98
[7]   Pathophysiology of sepsis [J].
Arina, Pietro ;
Singer, Mervyn .
CURRENT OPINION IN ANESTHESIOLOGY, 2021, 34 (02) :77-84
[8]   SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction [J].
Assimakopoulos, Stelios F. ;
Eleftheriotis, Gerasimos ;
Lagadinou, Maria ;
Karamouzos, Vassilios ;
Dousdampanis, Periklis ;
Siakallis, Georgios ;
Marangos, Markos .
MICROORGANISMS, 2022, 10 (05)
[9]   The liver-gut-axis: initiator and responder to sepsis [J].
Bauer, Michael .
CURRENT OPINION IN CRITICAL CARE, 2022, 28 (02) :216-220
[10]   The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis [J].
Bergstrom, Kirk ;
Xia, Lijun .
GUT MICROBES, 2022, 14 (01)